Poland· PL-100222418
Rutinoscorbin Plus
A ascorbic acid (vitamin c), combinations product containing preparat złożony, registered in Poland by GlaxoSmithKline Consumer Healthcare Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Preparat złożony is registered in 4 of 19 countries.
Countries holding a registration under ATC A11GB (ascorbic acid (vitamin c), combinations), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Preparat złożony · ATC A11GB
4 / 19 countries
- Finlandprice
- Ireland
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Preparat złożony
- Manufacturer
- GlaxoSmithKline Consumer Healthcare Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A11GB
- ATC class
- Ascorbic acid (vitamin C), combinations
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- June 21, 2026
Packs & prices · 2
- gtin05909990994519
- gtin05909990994526
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A11GB
Ascorbic acid (vitamin c), combinations, as other registers publish it.
- PolandCeelGrzegorz Nowakowski Przedsiębiorstwo Produkcji Farmaceutycznej "GEMI"
- SwitzerlandRedoxon + Zinc, BrausetablettenBayer (Schweiz) AG
- SwitzerlandRedoxon + Zinc, BrausetablettenBayer (Schweiz) AG
- SwitzerlandRedoxon + Zinc, BrausetablettenBayer (Schweiz) AG
- SwitzerlandRedoxon + Zinc, BrausetablettenBayer (Schweiz) AG
- SwitzerlandRedoxon + Zinc, KautablettenBayer (Schweiz) AG
- SwitzerlandRedoxon + Zinc, KautablettenBayer (Schweiz) AG
- IrelandRedoxon Double Action 1000 mg/10 mg Effervescent TabletsBayer Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/343314c4-2637-4181-8e5c-4ffb1fc12612 GET /v1/drugs/343314c4-2637-4181-8e5c-4ffb1fc12612?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "-",
"packaging": "05909990994519 ¦ OTC ¦ 20581\n30 tabl.\n05909990994526 ¦ OTC ¦ 20582\n60 tabl.",
"substance": "Acidum ascorbicum 100 mg + Rutosidum trihydricum 25 mg (w postaci rutozydu trójwodnego) + Zincum 2 mg ( w postaci cynku siarczanu jednowodnego - 5,5077 mg) + Selen 8 mcg ( w postaci sodu selenianu - 0,01913 mg)",
"common_name": "Preparat złożony",
"pl_product_id": "100222418",
"pozwolenie_nr": "09945",
"auth_procedure": "NAR",
"authorisation_validity": "2023-06-23"
}See everything about preparat złożony.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.